Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021

HomeHemovent GmbHHemovent Files Two Additional Patent Applications for its Portable ECMO Device for...

Hemovent Files Two Additional Patent Applications for its Portable ECMO Device for Both Circulatory and Respiratory Support

March 22, 2017

Hemovent GmbH, an emerging medical device company, announced today that it has filed two additional patents, for a gas exchanger and a pump—related to its novel and portable ExtraCorporeal Membrane Oxygenation (ECMO) device.

“Although ECMO has proven to be an effective treatment for acute respiratory and circulatory failure, and although our system’s portability is very likely to expand the use of ECMO, we fully expect that our Hemovent system will mitigate many device-related complications in standard ECMO, such as hemolysis, that manifest due to flow-pressure rate issues and blood-clotting as a result of stagnant flow and insufficient washout zones,” said Oliver Marseille, Ph.D., co-founder and chief technology officer.

“We believe Hemovent’s ECMO system is designed for superior blood-handling and more consistently superior patient outcomes compared to standard ECMO,” added Dr. Marseille. “For these reasons, we expect that when Hemovent is available by mid-2018 it will drive ECMO usage not only for applications such as Extracorporeal Cardio Pulmonary Resuscitation (ECPR) but also as an effective therapy for other cardiac and respiratory failure indications.”

Dr. Marseille was a co-founder of CircuLite® (HeartWare® International) prior to co-founding Hemovent—which is developing the world’s smallest and first self-contained, fully portable ECMO system designed to support or replace heart and lung function in the event of cardiac and respiratory failure.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy